Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
5.45
-0.28 (-4.89%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Cryo-Cell International Income Statement
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 28, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | 2015 - 2019 |
| Revenue | 32.1 | 31.99 | 31.34 | 30.34 | 28.88 | 31.15 | Upgrade
|
| Revenue Growth (YoY) | 2.33% | 2.05% | 3.32% | 5.03% | -7.26% | -2.10% | Upgrade
|
| Cost of Revenue | 7.87 | 7.95 | 12.13 | 8.79 | 10.15 | 10.94 | Upgrade
|
| Gross Profit | 24.24 | 24.04 | 19.22 | 21.54 | 18.73 | 20.21 | Upgrade
|
| Selling, General & Admin | 18.73 | 18.52 | 17.17 | 15.58 | 14.61 | 14.29 | Upgrade
|
| Research & Development | 0.84 | 1.24 | 1.17 | 0.38 | 0.05 | 0.02 | Upgrade
|
| Operating Expenses | 20.21 | 20.25 | 19.46 | 17.08 | 15.49 | 14.48 | Upgrade
|
| Operating Income | 4.03 | 3.79 | -0.25 | 4.46 | 3.24 | 5.72 | Upgrade
|
| Interest Expense | -2.06 | -1.86 | -1.24 | -1.08 | -1.38 | -1.54 | Upgrade
|
| Interest & Investment Income | 0.11 | 0.11 | 0.12 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| EBT Excluding Unusual Items | 2.08 | 2.04 | -1.36 | 3.39 | 1.86 | 4.18 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.46 | 0.77 | 0.05 | -0.04 | -0.01 | -0.01 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.41 | -0.02 | - | Upgrade
|
| Asset Writedown | - | - | -13.11 | - | - | - | Upgrade
|
| Other Unusual Items | -0 | -0 | 1.05 | -0.44 | 0.78 | 0.87 | Upgrade
|
| Pretax Income | 2.54 | 2.8 | -13.36 | 3.32 | 2.61 | 5.04 | Upgrade
|
| Income Tax Expense | 2.41 | 2.4 | -3.84 | 0.55 | 0.53 | 1.41 | Upgrade
|
| Net Income | 0.13 | 0.4 | -9.52 | 2.77 | 2.08 | 3.62 | Upgrade
|
| Net Income to Common | 0.13 | 0.4 | -9.52 | 2.77 | 2.08 | 3.62 | Upgrade
|
| Net Income Growth | - | - | - | 33.02% | -42.52% | 58.23% | Upgrade
|
| Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 8 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 8 | 8 | Upgrade
|
| Shares Change (YoY) | -1.35% | -1.54% | -1.69% | 1.46% | 2.72% | -3.24% | Upgrade
|
| EPS (Basic) | 0.02 | 0.05 | -1.14 | 0.33 | 0.26 | 0.48 | Upgrade
|
| EPS (Diluted) | 0.01 | 0.05 | -1.14 | 0.33 | 0.25 | 0.45 | Upgrade
|
| EPS Growth | - | - | - | 30.95% | -44.44% | 66.67% | Upgrade
|
| Free Cash Flow | 5.31 | 3.61 | 2.08 | -3.6 | 6.09 | 8.37 | Upgrade
|
| Free Cash Flow Per Share | 0.65 | 0.44 | 0.25 | -0.42 | 0.73 | 1.03 | Upgrade
|
| Dividend Per Share | 0.500 | 0.250 | - | - | - | - | Upgrade
|
| Gross Margin | 75.50% | 75.15% | 61.31% | 71.02% | 64.85% | 64.87% | Upgrade
|
| Operating Margin | 12.54% | 11.85% | -0.79% | 14.70% | 11.20% | 18.37% | Upgrade
|
| Profit Margin | 0.40% | 1.26% | -30.38% | 9.13% | 7.21% | 11.64% | Upgrade
|
| Free Cash Flow Margin | 16.55% | 11.28% | 6.64% | -11.85% | 21.09% | 26.86% | Upgrade
|
| EBITDA | 4.88 | 4.48 | 1.15 | 5.96 | 4.27 | 6.09 | Upgrade
|
| EBITDA Margin | 15.21% | 14.02% | 3.68% | 19.64% | 14.80% | 19.56% | Upgrade
|
| D&A For EBITDA | 0.86 | 0.69 | 1.4 | 1.5 | 1.04 | 0.37 | Upgrade
|
| EBIT | 4.03 | 3.79 | -0.25 | 4.46 | 3.24 | 5.72 | Upgrade
|
| EBIT Margin | 12.54% | 11.85% | -0.79% | 14.70% | 11.20% | 18.37% | Upgrade
|
| Effective Tax Rate | 94.94% | 85.66% | - | 16.50% | 20.21% | 28.07% | Upgrade
|
| Revenue as Reported | 32.1 | 31.99 | 31.34 | 30.34 | 28.88 | 31.15 | Upgrade
|
| Advertising Expenses | - | 1.07 | 0.95 | 0.76 | 0.84 | 0.85 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.